Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18315261
[patent_doc_number] => 11629332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Cell expansion
[patent_app_type] => utility
[patent_app_number] => 15/943619
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 40
[patent_no_of_words] => 40468
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15943619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/943619 | Cell expansion | Apr 1, 2018 | Issued |
Array
(
[id] => 16831050
[patent_doc_number] => 11007281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Nano/micromotors for active and dynamic intracellular payload delivery
[patent_app_type] => utility
[patent_app_number] => 15/939104
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 50
[patent_no_of_words] => 22230
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15939104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/939104 | Nano/micromotors for active and dynamic intracellular payload delivery | Mar 27, 2018 | Issued |
Array
(
[id] => 13982601
[patent_doc_number] => 20190060458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 15/927730
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927730 | Delivery and formulation of engineered nucleic acids | Mar 20, 2018 | Issued |
Array
(
[id] => 15571575
[patent_doc_number] => 10576146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Particles comprising a shell with RNA
[patent_app_type] => utility
[patent_app_number] => 15/922433
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 22936
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15922433
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/922433 | Particles comprising a shell with RNA | Mar 14, 2018 | Issued |
Array
(
[id] => 18747076
[patent_doc_number] => 11806367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Methods of treating lysosomal disorders
[patent_app_type] => utility
[patent_app_number] => 16/493573
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 33
[patent_no_of_words] => 17129
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493573 | Methods of treating lysosomal disorders | Mar 14, 2018 | Issued |
Array
(
[id] => 13314725
[patent_doc_number] => 20180208899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => EX VIVO PROLIFERATION OF EPITHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 15/921536
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/921536 | Ex vivo proliferation of epithelial cells | Mar 13, 2018 | Issued |
Array
(
[id] => 13314727
[patent_doc_number] => 20180208900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => EX VIVO PROLIFERATION OF EPITHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 15/921546
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921546
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/921546 | Ex vivo proliferation of epithelial cells | Mar 13, 2018 | Issued |
Array
(
[id] => 15493183
[patent_doc_number] => 20200046780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => FASL-ENGINEERED BIOMATERIALS WITH IMMUNOMODULATORY FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/492441
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492441 | FasL-engineered biomaterials with immunomodulatory function | Mar 8, 2018 | Issued |
Array
(
[id] => 16197327
[patent_doc_number] => 10722463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
[patent_app_type] => utility
[patent_app_number] => 15/913692
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12224
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/913692 | Compositions and methods using same for delivering agents into a target organ protected by a blood barrier | Mar 5, 2018 | Issued |
Array
(
[id] => 13618819
[patent_doc_number] => 20180360961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => MESSENGER RNA THERAPY FOR TREATMENT OF ARTICULAR DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/913783
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15913783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/913783 | Messenger RNA therapy for treatment of articular disease | Mar 5, 2018 | Issued |
Array
(
[id] => 14145897
[patent_doc_number] => 10253312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
[patent_app_type] => utility
[patent_app_number] => 15/904269
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 80
[patent_no_of_words] => 97781
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15904269
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/904269 | CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10) | Feb 22, 2018 | Issued |
Array
(
[id] => 13586443
[patent_doc_number] => 20180344770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Functionalized Erythroid Cells
[patent_app_type] => utility
[patent_app_number] => 15/932341
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15932341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/932341 | Functionalized erythroid cells | Feb 15, 2018 | Issued |
Array
(
[id] => 16247378
[patent_doc_number] => 10746728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Human trophoblast stem cells and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/892777
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 64
[patent_no_of_words] => 11809
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892777 | Human trophoblast stem cells and uses thereof | Feb 8, 2018 | Issued |
Array
(
[id] => 13774705
[patent_doc_number] => 20190000891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => MATERIALS AND METHODS FOR CONTROLLING VASCULOGENESIS FROM ENDOTHELIAL COLONY FORMING CELLS
[patent_app_type] => utility
[patent_app_number] => 15/891252
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891252 | Materials and methods for controlling vasculogenesis from endothelial colony forming cells | Feb 6, 2018 | Issued |
Array
(
[id] => 15848037
[patent_doc_number] => 10639277
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-05-05
[patent_title] => Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma
[patent_app_type] => utility
[patent_app_number] => 15/887316
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 32
[patent_no_of_words] => 28953
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887316 | Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma | Feb 1, 2018 | Issued |
Array
(
[id] => 18620591
[patent_doc_number] => 11753619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Engineered cells and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/482497
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 63
[patent_no_of_words] => 28625
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482497 | Engineered cells and methods of use | Jan 31, 2018 | Issued |
Array
(
[id] => 12912628
[patent_doc_number] => 20180196052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => METHODS FOR DETERMINING PROGNOSIS OF COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 15/876732
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876732
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876732 | Methods for determining prognosis of colorectal cancer | Jan 21, 2018 | Issued |
Array
(
[id] => 13387239
[patent_doc_number] => 20180245161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => Method of Diagnosing Cancer
[patent_app_type] => utility
[patent_app_number] => 15/875362
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875362 | Method of diagnosing cancer | Jan 18, 2018 | Issued |
Array
(
[id] => 15039305
[patent_doc_number] => 20190330657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => FUSOGENIC LIPID NANOPARTICLES AND METHODS FOR THE MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE, CONDITION, OR DISORDER ASSOCIATED WITH A TARGET CELL
[patent_app_type] => utility
[patent_app_number] => 16/476865
[patent_app_country] => US
[patent_app_date] => 2018-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476865 | Expression constructs, fusogenic lipid-based nanoparticles and methods of use thereof | Jan 8, 2018 | Issued |
Array
(
[id] => 15083479
[patent_doc_number] => 20190336550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => GENE THERAPY FOR TREATING PHENYLKETONURIA
[patent_app_type] => utility
[patent_app_number] => 16/474960
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474960
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474960 | Gene therapy for treating Phenylketonuria | Dec 28, 2017 | Issued |